These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30160173)

  • 1. Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: proof of concept study.
    Hedgire S; Krebill C; Wojtkiewicz GR; Oliveira I; Ghoshhajra BB; Hoffmann U; Harisinghani MG
    Br J Radiol; 2018 Dec; 91(1092):20180461. PubMed ID: 30160173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
    Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
    AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasmall Superparamagnetic Iron Oxide Imaging Identifies Tissue and Nerve Inflammation in Pain Conditions.
    Shen S; Ding W; Ahmed S; Hu R; Opalacz A; Roth S; You Z; Wotjkiewicz GR; Lim G; Chen L; Mao J; Chen JW; Zhang Y
    Pain Med; 2018 Apr; 19(4):686-692. PubMed ID: 29177411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T.
    Colbert CM; Ming Z; Pogosyan A; Finn JP; Nguyen KL
    J Magn Reson Imaging; 2023 Jun; 57(6):1819-1829. PubMed ID: 36250695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
    Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
    Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
    Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
    J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
    Morris JB; Olzinski AR; Bernard RE; Aravindhan K; Mirabile RC; Boyce R; Willette RN; Jucker BM
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):265-71. PubMed ID: 18162612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T.
    Stirrat CG; Alam SR; MacGillivray TJ; Gray CD; Forsythe R; Dweck MR; Payne JR; Prasad SK; Petrie MC; Gardner RS; Mirsadraee S; Henriksen PA; Newby DE; Semple SI
    J Cardiovasc Magn Reson; 2016 Jul; 18(1):46. PubMed ID: 27465647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis.
    Morishige K; Kacher DF; Libby P; Josephson L; Ganz P; Weissleder R; Aikawa M
    Circulation; 2010 Oct; 122(17):1707-15. PubMed ID: 20937980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.
    McConnell HL; Schwartz DL; Richardson BE; Woltjer RL; Muldoon LL; Neuwelt EA
    Nanomedicine; 2016 Aug; 12(6):1535-42. PubMed ID: 27071335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
    Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with histopathologic correlation.
    Hedgire SS; Mino-Kenudson M; Elmi A; Thayer S; Fernandez-del Castillo C; Harisinghani MG
    Int J Nanomedicine; 2014; 9():1891-6. PubMed ID: 24790431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach.
    Yilmaz A; Dengler MA; van der Kuip H; Yildiz H; Rösch S; Klumpp S; Klingel K; Kandolf R; Helluy X; Hiller KH; Jakob PM; Sechtem U
    Eur Heart J; 2013 Feb; 34(6):462-75. PubMed ID: 23103659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
    Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
    J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
    Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS
    Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
    Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Ferumoxytol in the Abdomen and Pelvis: A Dosing Study with 1.5- and 3.0-T MRI Relaxometry.
    Wells SA; Schubert T; Motosugi U; Sharma SD; Campo CA; Kinner S; Woo KM; Hernando D; Reeder SB
    Radiology; 2020 Jan; 294(1):108-116. PubMed ID: 31714191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.